129 related articles for article (PubMed ID: 32990784)
1. FIT: Functional and imaging testing for patients with metastatic cancer.
Roeland EJ; Phull H; Hagmann C; Sera C; Dullea AD; El-Jawahri A; Nelson S; Gallivan A; Ma JD; Nipp RD; Baracos VE
Support Care Cancer; 2021 May; 29(5):2771-2775. PubMed ID: 32990784
[TBL] [Abstract][Full Text] [Related]
2. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
3. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
4. Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
Brown LR; Sousa MS; Yule MS; Baracos VE; McMillan DC; Arends J; Balstad TR; Bye A; Dajani O; Dolan RD; Fallon MT; Greil C; Hjermstad MJ; Jakobsen G; Maddocks M; McDonald J; Ottestad IO; Phillips I; Sayers J; Simpson MR; Vagnildhaug OM; Solheim TS; Laird BJA; Skipworth RJE;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):816-852. PubMed ID: 38738581
[TBL] [Abstract][Full Text] [Related]
5. Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?
Valaire R; Garden F; Razmovski-Naumovski V
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1146-1156. PubMed ID: 38533530
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients.
Anderson LJ; Lee J; Mallen MC; Migula D; Liu H; Wu PC; Dash A; Garcia JM
Clin Nutr; 2021 Mar; 40(3):978-986. PubMed ID: 32713720
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of muscle strength and function in patients with cancer cachexia.
Gale N; Wasley D; Roberts S; Backx K; Nelson A; van Deursen R; Byrne A
Support Care Cancer; 2019 Jan; 27(1):131-137. PubMed ID: 29860710
[TBL] [Abstract][Full Text] [Related]
8. What are the criteria for response to cachexia treatment?
Crawford J
Ann Palliat Med; 2019 Jan; 8(1):43-49. PubMed ID: 30685983
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer.
LeBlanc TW; Nipp RD; Rushing CN; Samsa GP; Locke SC; Kamal AH; Cella DF; Abernethy AP
J Pain Symptom Manage; 2015 Apr; 49(4):680-9. PubMed ID: 25461669
[TBL] [Abstract][Full Text] [Related]
10. The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
Ramage MI; Skipworth RJE
Curr Opin Support Palliat Care; 2018 Dec; 12(4):439-444. PubMed ID: 30138131
[TBL] [Abstract][Full Text] [Related]
11. Establishing a cancer nutrition rehabilitation program (CNRP) for ambulatory patients attending an Australian cancer center.
Glare P; Jongs W; Zafiropoulos B
Support Care Cancer; 2011 Apr; 19(4):445-54. PubMed ID: 20204419
[TBL] [Abstract][Full Text] [Related]
12. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
13. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
[TBL] [Abstract][Full Text] [Related]
14. Body weight changes and incidence of cachexia after stroke.
Scherbakov N; Pietrock C; Sandek A; Ebner N; Valentova M; Springer J; Schefold JC; von Haehling S; Anker SD; Norman K; Haeusler KG; Doehner W
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):611-620. PubMed ID: 30680953
[TBL] [Abstract][Full Text] [Related]
15. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
[TBL] [Abstract][Full Text] [Related]
16. The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
Blauwhoff-Buskermolen S; Langius JAE; Becker A; Verheul HMW; de van der Schueren MAE
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):615-622. PubMed ID: 28447434
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
18. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Lester J; Parry D; Pettit RJ; Byrne A
BMC Cancer; 2015 Jul; 15():544. PubMed ID: 26204885
[TBL] [Abstract][Full Text] [Related]
19. Endpoints in clinical trials in cancer cachexia: where to start?
Laird BJA; Balstad TR; Solheim TS
Curr Opin Support Palliat Care; 2018 Dec; 12(4):445-452. PubMed ID: 30299325
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle function during the progression of cancer cachexia in the male Apc
VanderVeen BN; Hardee JP; Fix DK; Carson JA
J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
